Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew W Johnson

Showing results (151-160 of 176) with videos related to

Pageof 18
Sort By:
Experimental and Clinical Psychopharmacology|July 26, 2016
Cocaine-dependent adults and recreational cocaine users are more likely than controls to choose immediate unsafe sex over delayed safer sexMikhail N Koffarnus, Matthew W Johnson, Daisy G Y Thompson-Lake, et al.
Inflammatory Bowel Diseases|July 11, 2009
Osteoporosis in patients over 50 years of age following restorative proctocolectomy for ulcerative colitis: is DXA screening warranted?Simon D McLaughlin, Zarah L Perry-Woodford, Susan K Clark, et al.
Drug and Alcohol Dependence|December 12, 2023
Effect of nicotine expectancy and nicotine dose reduction on cigarette demand, withdrawal alleviation, and puff topographyJustin C Strickland, Brett W Gelino, Gideon P Naudé, et al.
Journal of Psychopharmacology (Oxford, England)|December 3, 2016
Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trialRoland R Griffiths, Matthew W Johnson, Michael A Carducci, et al.
Scientific Reports|October 3, 2020
The Acute Effects of the Atypical Dissociative Hallucinogen Salvinorin A on Functional Connectivity in the Human BrainManoj K Doss, Darrick G May, Matthew W Johnson, et al.
JAMA Psychiatry|November 4, 2020
Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder: A Randomized Clinical TrialAlan K Davis, Frederick S Barrett, Darrick G May, et al.
Journal of Psychoactive Drugs|February 8, 2025
Shame, Guilt and Psychedelic Experience: Results from a Prospective, Longitudinal Survey of Real-World Psilocybin UseDavid S Mathai, Daniel E Roberts, Sandeep M Nayak, et al.
The International Journal of Neuropsychopharmacology|May 14, 2021
Psychedelics and Consciousness: Distinctions, Demarcations, and OpportunitiesDavid B Yaden, Matthew W Johnson, Roland R Griffiths, et al.
Pharmacological Research|November 29, 2023
IUPHAR-review: The integration of classic psychedelics into current substance use disorder treatment modelsDavid B Yaden, Andrea P Berghella, Peter S Hendricks, et al.
Journal of Child & Adolescent Substance Abuse|December 8, 2018
Working Memory Training for Adolescents With Cannabis Use Disorders: A Randomized Controlled TrialMary M Sweeney, Olga Rass, Cara DiClemente, et al.
Pageof 18

Showing results (151-160 of 176) with videos related to

Sort By:
Pageof 18
Experimental and Clinical Psychopharmacology|July 26, 2016
Cocaine-dependent adults and recreational cocaine users are more likely than controls to choose immediate unsafe sex over delayed safer sexMikhail N Koffarnus, Matthew W Johnson, Daisy G Y Thompson-Lake, et al.
Inflammatory Bowel Diseases|July 11, 2009
Osteoporosis in patients over 50 years of age following restorative proctocolectomy for ulcerative colitis: is DXA screening warranted?Simon D McLaughlin, Zarah L Perry-Woodford, Susan K Clark, et al.
Drug and Alcohol Dependence|December 12, 2023
Effect of nicotine expectancy and nicotine dose reduction on cigarette demand, withdrawal alleviation, and puff topographyJustin C Strickland, Brett W Gelino, Gideon P Naudé, et al.
Journal of Psychopharmacology (Oxford, England)|December 3, 2016
Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trialRoland R Griffiths, Matthew W Johnson, Michael A Carducci, et al.
Scientific Reports|October 3, 2020
The Acute Effects of the Atypical Dissociative Hallucinogen Salvinorin A on Functional Connectivity in the Human BrainManoj K Doss, Darrick G May, Matthew W Johnson, et al.
JAMA Psychiatry|November 4, 2020
Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder: A Randomized Clinical TrialAlan K Davis, Frederick S Barrett, Darrick G May, et al.
Journal of Psychoactive Drugs|February 8, 2025
Shame, Guilt and Psychedelic Experience: Results from a Prospective, Longitudinal Survey of Real-World Psilocybin UseDavid S Mathai, Daniel E Roberts, Sandeep M Nayak, et al.
The International Journal of Neuropsychopharmacology|May 14, 2021
Psychedelics and Consciousness: Distinctions, Demarcations, and OpportunitiesDavid B Yaden, Matthew W Johnson, Roland R Griffiths, et al.
Pharmacological Research|November 29, 2023
IUPHAR-review: The integration of classic psychedelics into current substance use disorder treatment modelsDavid B Yaden, Andrea P Berghella, Peter S Hendricks, et al.
Journal of Child & Adolescent Substance Abuse|December 8, 2018
Working Memory Training for Adolescents With Cannabis Use Disorders: A Randomized Controlled TrialMary M Sweeney, Olga Rass, Cara DiClemente, et al.
Pageof 18